Home / Stocks / DNLI

DNLI insider trading

Denali Therapeutics Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-07-11Watts Ryan J.
President and CEO
Sold495,282$15.00$7.4M
2024-11-13Schenkein David P
Director
Sold32,312$32.87$1.1M
2024-10-22Watts Ryan J.
President and CEO
Sold40,000$27.69$1.1M

See DNLI on the chart

Every insider buy and sell for DNLI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.